Journal of hepatology, 2017-06, Vol.66 (6), p.1138-1148
- Calleja, Jose Luis
- Crespo, Javier
- Rincón, Diego
- Ruiz-Antorán, Belén
- Fernandez, Inmaculada
- Perelló, Christie
- Gea, Francisco
- Lens, Sabela
- García-Samaniego, Javier
- Sacristán, Begoña
- García-Eliz, María
- Llerena, Susana
- Pascasio, Juan Manuel
- Turnes, Juan
- Torras, Xavier
- Morillas, Rosa Maria
- Llaneras, Jordi
- Serra, Miguel A
- Diago, Moises
- Fernández Rodriguez, Conrado
- Ampuero, Javier
- Jorquera, Francisco
- Simon, Miguel A
- Arenas, Juan
- Navascues, Carmen Alvarez
- Bañares, Rafael
- Muñoz, Raquel
- Albillos, Agustin
- Mariño, Zoe
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Calleja, Jose Luis
- Crespo, Javier
- Rincón, Diego
- Ruiz-Antorán, Belén
- Fernandez, Inmaculada
- Perelló, Christie
- Gea, Francisco
- Lens, Sabela
- García-Samaniego, Javier
- Sacristán, Begoña
- García-Eliz, María
- Llerena, Susana
- Pascasio, Juan Manuel
- Turnes, Juan
- Torras, Xavier
- Morillas, Rosa Maria
- Llaneras, Jordi
- Serra, Miguel A
- Diago, Moises
- Fernández Rodriguez, Conrado
- Ampuero, Javier
- Jorquera, Francisco
- Simon, Miguel A
- Arenas, Juan
- Navascues, Carmen Alvarez
- Bañares, Rafael
- Muñoz, Raquel
- Albillos, Agustin
- Mariño, Zoe
- Titel
- Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: results from a Spanish real world cohort
- Ist Teil von
- Journal of hepatology, 2017-06, Vol.66 (6), p.1138-1148
- Ort / Verlag
- Netherlands: Elsevier B.V
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Graphical abstract
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0168-8278eISSN: 1600-0641DOI: 10.1016/j.jhep.2017.01.028Titel-ID: cdi_proquest_journals_2080989662
- Format
- –
- Schlagworte
- Adult, Aged, Aged, 80 and over, Anilides - administration & dosage, Antiviral agents, Antiviral Agents - administration & dosage, Antiviral Agents - adverse effects, Antiviral Agents - therapeutic use, Antiviral drugs, Benzimidazoles - administration & dosage, Carbamates - administration & dosage, Carcinoma, Hepatocellular - etiology, Chronic infection, Clinical outcomes, Clinical trials, Cohort analysis, Cohort Studies, Dasabuvir, Data processing, Drug therapy, Drug Therapy, Combination, Female, Fibrosis, Fluorenes - administration & dosage, Gastroenterology and Hepatology, Genotype, Genotype & phenotype, Genotype 1, Genotypes, Glomerular Filtration Rate, Hepacivirus - genetics, Hepatitis C, Hepatitis C, Chronic, Hepatitis C, Chronic - drug therapy, Hepatitis C, Chronic - physiopathology, Hepatitis C, Chronic - virology, Hepatocellular carcinoma, Humans, Ledipasvir, Liver Neoplasms - etiology, Macrocyclic Compounds - administration & dosage, Male, Middle Aged, Multivariate analysis, Neoplasm Recurrence, Local - etiology, Ombitasvir, Paritaprevir, Patients, Randomized controlled trials, Real-world, Retrospective Studies, Ribavirin, Ribavirin - administration & dosage, Ritonavir, Ritonavir - administration & dosage, Safety, Sofosbuvir, Spain, Sulfonamides - administration & dosage, Sustained Virologic Response, Treatment Outcome, Uracil - administration & dosage, Uracil - analogs & derivatives, Uridine Monophosphate - administration & dosage, Uridine Monophosphate - analogs & derivatives, Young Adult